Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'flesinoxan' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 78 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. van der Sandt, ICJ; Smolders, R; Nabulsi, L; Zuideveld, KP; de Boer, AG; Breimer, DD
      Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoproteinat the blood-brain barrier

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    2. Millan, MJ; Brocco, M; Gobert, A; Dorey, G; Casara, P; Dekeyne, A
      Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: A comparison to other classes of anxiolytic agent

      NEUROPSYCHOPHARMACOLOGY
    3. Blanchard, DC; Griebel, G; Blanchard, RJ
      Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    4. Li, XB; Inoue, T; Hashimoto, S; Koyama, T
      Effect of chronic administration of flesinoxan and fluvoxamine on freezingbehavior induced by conditioned fear

      EUROPEAN JOURNAL OF PHARMACOLOGY
    5. Pattij, T; Hijzen, TH; Groenink, L; Oosting, RS; van der Gugten, J; Maes, RAA; Hen, R; Olivier, B
      Stress-induced hyperthermia in the 5-HT1A receptor knockout mouse is normal

      BIOLOGICAL PSYCHIATRY
    6. Bouwknecht, JA; van der Gugten, J; Hijzen, TH; Maes, RAA; Hen, R; Olivier, B
      Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal

      PSYCHOPHARMACOLOGY
    7. Gommans, J; Hijzen, TH; Maes, RA; Olivier, B
      Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    8. Groenink, L; Joordens, RJE; Hijzen, TH; Dirks, A; Olivier, B
      Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle

      NEUROREPORT
    9. Dulawa, SC; Gross, C; Stark, KL; Hen, R; Geyer, MA
      Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition

      NEUROPSYCHOPHARMACOLOGY
    10. Den Boer, JA; Bosker, FJ; Slaap, BR
      Serotonergic drugs in the treatment of depressive and anxiety disorders

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    11. Hansenne, M; Pitchot, W; Pinto, E; Papart, P; Ansseau, M
      Serotonergic-1a activity and contingent negative variation

      BIOLOGICAL PSYCHOLOGY
    12. Hillegaart, V; Magnusson, O; Ahlenius, S
      A9 and A10 dopamine nuclei as a site of action for effects of 8-OH-DPAT onlocomotion in the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    13. Sibug, RM; Compaan, JC; Meijer, OC; Van der Gugten, J; Olivier, B; De Kloet, ER
      Effects of flesinoxan on corticosteroid receptor expression in the rat hippocampus

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Suwabe, A; Kubota, M; Niwa, M; Kobayashi, K; Kanba, S
      Effect of a 5-HT1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats

      BRAIN RESEARCH
    15. Tsuji, M; Takeda, H; Matsumiya, T
      Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test

      PSYCHOPHARMACOLOGY
    16. Haddjeri, N; Ortemann, C; de Montigny, C; Blier, P
      Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    17. Hansenne, M; Ansseau, M
      P300 event-related potential and serotonin-1A activity in depression

      EUROPEAN PSYCHIATRY
    18. Hansenne, M; Ansseau, M
      Harm avoidance and serotonin

      BIOLOGICAL PSYCHOLOGY
    19. Cryan, JF; Kelliher, P; Kelly, JP; Leonard, BE
      Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635

      JOURNAL OF PSYCHOPHARMACOLOGY
    20. Olivier, B; Gommans, J; Van der Gugten, J; Bouwknecht, JA; Herremans, AHJ; Patty, T; Hijzen, TH
      Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    21. Herremans, AHJ; Van der Heyden, JAM; Van Drimmelen, M; Olivier, B
      The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    22. HANSENNE M; PITCHOT W; PAPART P; ANSSEAU M
      SEROTONERGIC MODULATION OF THE P300 EVENT-RELATED BRAIN POTENTIAL

      Human psychopharmacology
    23. LEE JY; HANCOCK AA; WARNER RB; BRUNE ME; MEYER MD; DEBERNARDIS JF
      CARDIOVASCULAR ACTIVITY OF A-74283, A 5-HYDROXYTRYPTAMINE(1A) AGENT, IN THE SPONTANEOUSLY HYPERTENSIVE RAT

      Pharmacology
    24. SUGIMOTO Y; YAMADA J; NOMA T
      EFFECTS OF ANXIOLYTICS, DIAZEPAM AND TANDOSPIRONE, ON IMMOBILIZATION STRESS-INDUCED HYPERGLYCEMIA IN MICE

      Life sciences (1973)
    25. DEVRY J; JENTZSCH KR
      DISCRIMINATIVE STIMULUS PROPERTIES OF THE 5-HT1A RECEPTOR AGONIST BAYX3702 IN THE RAT

      European journal of pharmacology
    26. SIBUG RM; COMPAAN JC; MEIJER OC; VANDERGUGTEN J; OLIVIER B; DEKLOET ER
      FLESINOXAN TREATMENT REDUCES 5-HT1A RECEPTOR MESSENGER-RNA IN THE DENTATE GYRUS INDEPENDENTLY OF HIGH PLASMA-CORTICOSTERONE LEVELS

      European journal of pharmacology
    27. OLIVIER B; ZETHOF TJJ; RONKEN E; VANDERHEYDEN JAM
      ANXIOLYTIC EFFECTS OF FLESINOXAN IN THE STRESS-INDUCED HYPERTHERMIA PARADIGM IN SINGLY-HOUSED MICE ARE 5-HT1A RECEPTOR-MEDIATED

      European journal of pharmacology
    28. Gommans, J; Bouwknecht, JA; Hijzen, TH; Berendsen, HHG; Broekkamp, CLE; Maes, RAA; Olivier, B
      Stimulus properties of fluvoxamine in a conditioned taste aversion procedure

      PSYCHOPHARMACOLOGY
    29. JOORDENS RJE; HIJZEN TH; OLIVIER B
      THE EFFECTS OF 5-HT1A RECEPTOR AGONISTS, 5-HT1A RECEPTOR ANTAGONISTS AND THEIR INTERACTION ON THE FEAR-POTENTIATED STARTLE RESPONSE

      Psychopharmacology
    30. MICZEK KA; HUSSAIN S; FACCIDOMO S
      ALCOHOL-HEIGHTENED AGGRESSION IN MICE - ATTENUATION BY 5-HT1A RECEPTOR AGONISTS

      Psychopharmacology
    31. CRYAN JF; REDMOND AM; KELLY JP; LEONARD BE
      THE EFFECTS OF THE 5-HT1A AGONIST FLESINOXAN, IN 3 PARADIGMS FOR ASSESSING ANTIDEPRESSANT POTENTIAL IN THE RAT

      European neuropsychopharmacology
    32. BAUMANN P; BERTSCHY G
      LONG-TERM TREATMENT OF DEPRESSION - IS THERE A USE FOR DEPOT ANTIDEPRESSANTS

      International clinical psychopharmacology
    33. CHAOUCHETEYARA K; LACOLLEY P; CHALLANDE P; FOURNIER B; LAURENT S; SAFAR M; DABIRE H
      EFFECTS OF CLONIDINE AND FLESINOXAN ON BLOOD-PRESSURE VARIABILITY IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS

      Journal of cardiovascular pharmacology
    34. BOSKER F; VRINTEN D; KLOMPMAKERS A; WESTENBERG H
      THE EFFECTS OF A 5-HT1A RECEPTOR AGONIST AND ANTAGONIST ON THE 5-HYDROXYTRYPTAMINE RELEASE IN THE CENTRAL NUCLEUS OF THE AMYGDALA - A MICRODIALYSIS STUDY WITH FLESINOXAN AND WAY-100635

      Naunyn-Schmiedeberg's archives of pharmacology
    35. GOMMANS J; HIJZEN TH; MAES RA; OLIVIER B
      DISCRIMINATIVE STIMULUS PROPERTIES OF ELTOPRAZINE

      Life sciences
    36. WOLFF MC; LEANDER JD
      DIFFERENTIATION OF 5-HT1A RECEPTOR LIGANDS BY DRUG DISCRIMINATION

      European journal of pharmacology
    37. BOSKER FJ; KLOMPMAKERS A; WESTENBERG HGM
      POSTSYNAPTIC 5-HT1A RECEPTORS MEDIATE 5-HYDROXYTRYPTAMINE RELEASE IN THE AMYGDALA THROUGH A FEEDBACK TO THE CAUDAL LINEAR RAPHE

      European journal of pharmacology
    38. HAENSEL SM; SLOB AK
      FLESINOXAN - A PROSEXUAL DRUG FOR MALE-RATS

      European journal of pharmacology
    39. KING CMF; GOMMANS J; JOORDENS RJE; HIJZEN TH; MAES RAA; OLIVIER B
      EFFECTS OF 5-HT1A RECEPTOR LIGANDS IN A MODIFIED GELLER-SEIFTER CONFLICT MODEL IN THE RAT

      European journal of pharmacology
    40. MOS J; VANHEST A; VANDRIMMELEN M; HERREMANS AHJ; OLIVIER B
      THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST DU125530 BLOCKS THE DISCRIMINATIVE STIMULUS OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN PIGEONS

      European journal of pharmacology
    41. HANSENNE M; PITCHOT W; MORENO AG; REGGERS J; MACHUROT PY; ANSSEAU M
      HARM AVOIDANCE DIMENSION OF THE TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE AND SEROTONIN-1A ACTIVITY IN DEPRESSED-PATIENTS

      Biological psychiatry
    42. GROENINK L; VANDERGUGTEN J; COMPAAN JC; MAES RAA; OLIVIER B
      FLESINOXAN PRETREATMENT DIFFERENTIALLY AFFECTS CORTICOSTERONE, PROLACTIN AND BEHAVIORAL-RESPONSES TO A FLESINOXAN CHALLENGE

      Psychopharmacology
    43. DRYDEN S; WANG QO; FRANKISH HM; WILLIAMS G
      DIFFERENTIAL-EFFECTS OF THE 5-HT1B 2C RECEPTOR AGONIST MCPP AND THE 5-HT1A AGONIST FLESINOXAN ON HYPOTHALAMIC NEUROPEPTIDE-Y IN THE RAT - EVIDENCE THAT NPY MAY MEDIATE SEROTONINS EFFECTS ON FOOD-INTAKE/

      Peptides
    44. HOSOHATA Y; SASAKI K; OHSHIMA C; ABE J; HATTORI K; SUZUKI J; WATANABE K; NAGATOMO T
      A NONSELECTIVE BETA-BLOCKER, BOPINDOLOL, EXHIBITS HIGH-AFFINITY TO 5-HT1A RECEPTOR SUBTYPE IN RAT-BRAIN AS ASSAYED BY COMPETITION BINDING EXPERIMENTS

      Biogenic amines
    45. GOODWIN GM
      HOW DO ANTIDEPRESSANTS AFFECT SEROTONIN RECEPTORS - THE ROLE OF SEROTONIN RECEPTORS IN THE THERAPEUTIC AND SIDE-EFFECT PROFILE OF THE SSRIS

      The Journal of clinical psychiatry
    46. GROENINK L; VANDERGUGTEN J; ZETHOF TJJ; VANDERHEYDEN JAM; OLIVIER B
      NEUROENDOCRINE EFFECTS OF DIAZEPAM AND FLESINOXAN IN THE STRESS-INDUCED HYPERTHERMIA TEST IN MICE

      Pharmacology, biochemistry and behavior
    47. BOSKER FJ; DEWINTER TYCE; KLOMPMAKERS AA; WESTENBERG HGM
      FLESINOXAN DOSE-DEPENDENTLY REDUCES EXTRACELLULAR 5-HYDROXYTRYPTAMINE(5-HT) IN RAT MEDIAN RAPHE AND DORSAL HIPPOCAMPUS THROUGH ACTIVATION OF 5-HT1A RECEPTORS

      Journal of neurochemistry
    48. KLEVEN M; PRINSSEN EPM; KOEK W
      ROLE OF 5-HT1A RECEPTORS IN THE ABILITY OF MIXED 5-HT1A RECEPTOR AGONIST DOPAMINE D-2 RECEPTOR ANTAGONISTS TO INHIBIT METHYLPHENIDATE-INDUCED BEHAVIORS IN RATS/

      European journal of pharmacology
    49. MAES JHR; VANRIJN CM; VOSSEN JMH
      DRUG STATES AS MODULATORS OF CONDITIONED IMMOBILITY IN A LATENT DISCRIMINATION PROCEDURE

      European journal of pharmacology
    50. CHAMIENIA AL; JOHNS EJ
      THE CARDIOVASCULAR AND RENAL FUNCTIONAL-RESPONSES TO THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN 2 RAT MODELS OF HYPERTENSION

      British Journal of Pharmacology
    51. VANVLIET IM; WESTENBERG HGM; DENBOER JA
      EFFECTS OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN PANIC DISORDER

      Psychopharmacology
    52. JOORDENS RJE; HIJZEN TH; PEETERS BWMM; OLIVIER B
      FEAR-POTENTIATED STARTLE RESPONSE IS REMARKABLY SIMILAR IN 2 LABORATORIES

      Psychopharmacology
    53. SELETTI B; BENKELFAT C; BLIER P; ANNABLE L; GILBERT F; DEMONTIGNY C
      SEROTONIN(1A) RECEPTOR ACTIVATION BY FLESINOXAN IN HUMANS - BODY-TEMPERATURE AND NEUROENDOCRINE RESPONSES

      Neuropsychopharmacology
    54. DIOUF O; DEPREUX P; LESIEUR D; POUPAERT JH; CAIGNARD DH
      6-(N-IMIDOALKYL)AMINOALKYLBENZOTHIAZOLIN-2-ONES AS LIGANDS OF THE SEROTONINERGIC 5-HT1A RECEPTORS

      Heterocycles
    55. DEKONING P; DEVRIES MH
      A COMPARISON OF THE NEURO-ENDOCRINOLOGIC AND TEMPERATURE EFFECTS OF DU-29894, FLESINOXAN, SULPIRIDE AND HALOPERIDOL IN NORMAL VOLUNTEERS

      British journal of clinical pharmacology
    56. HERREMANS AHJ; HIJZEN TH; OLIVIER B; SLANGEN JL
      SEROTONERGIC DRUG EFFECTS ON A DELAYED CONDITIONAL DISCRIMINATION TASK IN THE RAT - INVOLVEMENT OF THE 5-HT1A RECEPTOR IN WORKING-MEMORY

      JOURNAL OF PSYCHOPHARMACOLOGY
    57. HADRAVA V; BLIER P; DENNIS T; ORTEMANN C; DEMONTIGNY C
      CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE(1A) PROPERTIES OF FLESINOXAN - IN-VIVO ELECTROPHYSIOLOGY AND HYPOTHERMIA STUDY

      Neuropharmacology
    58. VANSTEEN BJ; VANWIJNGAARDEN I; TULP MTM; SOUDIJN W
      A SERIES OF N4-IMIDOETHYL DERIVATIVES OF 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZINE AS 5-HT1A RECEPTOR LIGANDS - SYNTHESIS AND STRUCTURE-AFFINITY RELATIONSHIPS

      Journal of medicinal chemistry
    59. GOMMANS J; HIJZEN TH; MAES RA; MOS J; OLIVIER B
      DISCRIMINATIVE STIMULUS PROPERTIES OF FLESINOXAN - EFFECTS OF ENANTIOMERS, (S)-UH301 AND WAY-100635

      European journal of pharmacology
    60. GROENINK L; VANDERGUGTEN J; VERDOUW PM; MAES RAA; OLIVIER B
      THE ANXIOLYTIC EFFECTS OF FLESINOXAN, A 5-HT1A RECEPTOR AGONIST, ARE NOT RELATED TO ITS NEUROENDOCRINE EFFECTS

      European journal of pharmacology
    61. GROENINK L; VANDERGUGTEN J; MOS J; MAES RAA; OLIVIER B
      THE CORTICOSTERONE-ENHANCING EFFECTS OF THE 5-HT(1A) RECEPTOR ANTAGONIST,(S)-UH301, ARE NOT MEDIATED BY THE 5-HT(1A) RECEPTOR

      European journal of pharmacology
    62. BRUNING TA; VANZWIETEN PA; BLAUW GJ; CHANG PC
      NO FUNCTIONAL INVOLVEMENT OF 5-HYDROXYTRYPTAMINE(1A) RECEPTORS IN NITRIC OXIDE-DEPENDENT DILATATION CAUSED BY SEROTONIN IN THE HUMAN FOREARM VASCULAR BED

      Journal of cardiovascular pharmacology
    63. ELMAS MM; CARROLL RG; ABDELRAHMAN AA
      CENTRALLY MEDIATED REDUCTION IN CARDIAC-OUTPUT ELICITS THE ENHANCED HYPOTENSIVE EFFECT OF CLONIDINE IN CONSCIOUS AORTIC BARODENERVATED RATS

      Journal of cardiovascular pharmacology
    64. RODGERS RJ; COLE JC; DAVIES A
      ANTIANXIETY AND BEHAVIORAL SUPPRESSANT ACTIONS OF THE NOVEL 5-HT1A RECEPTOR AGONIST, FLESINOXAN

      Pharmacology, biochemistry and behavior
    65. YBEMA CE; SLANGEN JL; OLIVIER B
      DISCRIMINATIVE STIMULUS EFFECT OF FLESINOXAN - EFFECTS OF 5-HT1A ANTAGONISTS AND PCPA

      Pharmacology, biochemistry and behavior
    66. KASAMO K; TADA K; UEDA N; KOJIMA T; KOGURE M; ISHIKAWA K
      EFFECTS OF SEVERAL 5-HT1A AGONISTS ON HIPPOCAMPAL RHYTHMICAL SLOW ACTIVITY IN UNANESTHETIZED RATS

      Neuropharmacology
    67. YBEMA CE; OLIVIER B; MOS J; TULP MTM; SLANGEN JL
      ADRENOCEPTORS AND DOPAMINE-RECEPTORS ARE NOT INVOLVED IN THE DISCRIMINATIVE STIMULUS EFFECT OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN

      European journal of pharmacology
    68. CRITCHLEY DJP; MIDDLEFELL VC; LIDDLE CW; FODEN ND; DOURISH CT
      EFFECTS OF THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY100135 AND ITSENANTIOMERS ON 8-OH-DPAT-INDUCED HYPERGLYCEMIA IN CONSCIOUS RATS

      European journal of pharmacology
    69. CHAMIENIA AL; JOHNS EJ
      THE RENAL FUNCTIONAL-RESPONSES TO 5-HT1A RECEPTOR AGONIST, FLESINOXAN, IN ANESTHETIZED, NORMOTENSIVE RAT

      British Journal of Pharmacology
    70. LEISHMAN DJ; BOEIJINGA PH; GALVAN M
      DIFFERENTIAL-EFFECTS OF CENTRALLY-ACTIVE ANTIHYPERTENSIVES ON 5-HT1A RECEPTORS IN RAT DORSOLATERAL SEPTUM, RAT HIPPOCAMPUS AND GUINEA-PIG HIPPOCAMPUS

      British Journal of Pharmacology
    71. KULIKOV AV; KOLPAKOV VG; MASLOVA GB; KOZINTSEV I; POPOVA NK
      EFFECT OF SELECTIVE 5-HT1A AGONISTS AND 5-HT2 ANTAGONISTS ON INHERITED CATALEPSY IN RATS

      Psychopharmacology
    72. ANSSEAU M; PITCHOT W; MORENO AG; WAUTHY J; PAPART P
      PILOT-STUDY OF FLESINOXAN, A 5-HT1A AGONIST, IN MAJOR DEPRESSION - EFFECTS ON SLEEP REM LATENCY AND BODY-TEMPERATURE

      Human psychopharmacology
    73. GROF P; JOFFE R; KENNEDY S; PERSAD E; SYROTIUK J; BRADFORD D
      AN OPEN STUDY OF ORAL FLESINOXAN, A 5-HT(1A) RECEPTOR AGONIST, IN TREATMENT-RESISTANT DEPRESSION

      International clinical psychopharmacology
    74. PERTZ H
      5-HYDROXYTRYPTAMINE (5-HT) CONTRACTS THE GUINEA-PIG ISOLATED ILIAC ARTERY VIA 5-HT(1)-LIKE AND 5-HT(2) RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    75. LANFUMEY L; HAJDAHMANE S; HAMON M
      FURTHER ASSESSMENT OF THE ANTAGONIST PROPERTIES OF THE NOVEL AND SELECTIVE 5-HT(1A) RECEPTOR LIGANDS (-WAY-100-135 AND SDZ-216-525())

      European journal of pharmacology
    76. CHAOUCHETEYARA K; DABIRE H; FOURNIER B; SAFAR M
      SYSTEMIC AND REGIONAL HEMODYNAMIC-EFFECTS OF DOI, IN THE ANESTHETIZEDRAT - IMPLICATION OF BOTH PERIPHERAL AND CENTRAL 5-HT2 RECEPTORS

      Archives des maladies du coeur et des vaisseaux
    77. BARRETT JE; VANOVER KE
      5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS

      Psychopharmacology
    78. ENSLER K; RYAN CN; EVENDEN JL
      EFFECTS OF REPEATED TREATMENT WITH 5-HT(1A) AGONISTS ON ACTIVE-AVOIDANCE RESPONDING IN THE RAT

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 00:12:22